Over the past decade, clinical trial data has become increasingly complex, leading to disconnects between key stakeholders and inefficiencies within drug development. As clinical operations teams become leaner and more cost-constrained, there is a growing demand for more advanced clinical trial analytics tools to better manage fragmented data.
In this webinar, the featured speakers will walk through four case studies and review all aspects of applying analytics to a study from operational and technical implementation to return on investment (ROI) and key performance indicators (KPIs) to measure success.
Register for this webinar to explore the evolution of clinical trial analytics and how they help predict clinical trial outcomes.
Rohit Nambisan, CEO & Co-Founder, Lokavant
Trained as a neuroscientist, Rohit Nambisan is a product executive with experience leading product development organizations in pharma, medical devices, personalized medicine, health IT, healthcare data and analytics and AI. Prior to co-founding and leading Lokavant, Rohit was most recently the Head of Digital Product at Roivant and the Head of Product at Prognos Health. Rohit holds an MS in management and engineering from MIT, an MA in neuroscience from Boston University and a BA in cognitive neuroscience from UC Berkeley.
Bill Symonds, CEO, Enzyvant
Dr. Bill Symonds became the President and Chief Executive Officer of Enzyvant in 2022. Previously, Dr. Symonds served as the Chief Executive Officer of Altavant Sciences, starting at its inception in 2018.
Dr. Symonds was a member of the founding management team at Roivant Sciences, Inc. where he served as Roivant’s Chief Development Officer. In that role, Dr. Symonds crafted the research and development plans for several products including rodatristat ethyl for the treatment of pulmonary arterial hypertension and was instrumental in the licensing and early development of RETHYMIC®.
Earlier in his career, Dr. Symonds held senior positions at a number of pharmaceutical companies including Pharmasset, Inc. and Gilead Sciences, Inc. During his tenure at Pharmasset, Dr. Symonds led the development of Sovaldi® for hepatitis C virus infection. Based on the early success at Pharmasset, Dr. Symonds and his team were brought into Gilead after its acquisition of Pharmasset, where he continued to advance Sovaldi® through to the US Food and Drug Administration (FDA) approval. Previously, he worked at GlaxoSmithKline and its predecessor companies on numerous approved medicines for HIV infection including Ziagen®, Agenerase® and Epzicom®.
Dr. Symonds received his Doctor of Pharmacy degree from Campbell University and completed a fellowship in clinical pharmacokinetics at the Clinical Pharmacokinetics Laboratory at Millard Fillmore Hospital in Buffalo, New York. He has authored or co-authored over 35 clinical articles and is named on nine patents related to the composition of matter and methods of use of drugs for hepatitis C infection.
Who Should Attend?
Senior professionals who are in:
- Clinical Operations/Development/Research
- Therapeutic Area Leads
- Study Management
- Digital Innovation
- Decentralized Trials
- Patient Solutions
- Clinical IT
- Chief Medical Officers
- Chief Scientific Officers
- Medical Affairs and HEOR
What You Will Learn
Attendees will gain insights into:
- How to implement analytics into a clinical trial strategy whether just getting started or for more advanced models to predict enrollment timelines
- Common use-cases for clinical trial analytics with relevant case studies
- The ROI that analytics provide in clinical trials from start-up to close-out
- Regulatory and compliance considerations when implementing analytics into a clinical study
Lokavant is a clinical intelligence platform that improves the time, cost, and quality of trial planning and execution through data-driven analytics applications. Lokavant’s platform aggregates and integrates real-time data from disparate trial data sources, and powers advanced analytics enabled by its compendium of proprietary trial data. The suite of applications built on the platform allows study teams to proactively plan and manage their studies and surface insights, driving efficiencies in all scientific and operational use cases. To learn more visit www.lokavant.com